Evidence map›Paper›PMID 27740602›Full record

ReviewJournal of clinical medicine2016

Multiple Roles for B-Lymphocytes in Sjogren's Syndrome.

Julian Lawrence Ambrus, Lakshmanan Suresh, Ammon Peck

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Trial
  3. CD226Frontiers in immunology · 2025
    Article
  4. Article
  5. Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome.Investigative ophthalmology & visual science · 2022
    Article
  6. Article
  7. P2YArchives of oral biology · 2021
    Article
  8. Article
  9. Article
  10. P2YOral diseases · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Julian Lawrence AmbrusDivision of Allergy, Immunology and Rheumatology, SUNY at Buffalo School of Medicine, 100 High Street, Buffalo, NY 14203, USA. jambrus@buffalo.edu.
Lakshmanan SureshImmco Diagnostics and the Department of Oral Diagnostic Sciences, SUNY at Buffalo School of Dental Science, Buffalo, NY 14203, USA. lsuresh@immco.com.
Ammon PeckCollege of Veterinary Medicine University of Florida, Gainesville, FL 32608, USA. peck@pathology.ufl.edu.
IMMCO Diagnostics (United States) · USUniversity at Buffalo, State University of New York · USUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sjogren's syndrome (SS) is a complex heterogeneous autoimmune disease resulting in loss of salivary gland and lacrimal gland function that may include multiple systemic manifestations including lymphoma. Multiple cell types participate in disease pathogenesis. This review discusses evidence for abnormal B cell subpopulations in patients with SS, critical roles of B cells in SS and the status of B cell-directed therapies in the management of patients with SS.

Indexed as

B cellsmarginal zone B cellsSjogren’s syndrome

Identifiers

PMID27740602
PMCPMC5086589
OpenAlexW2529618366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.